Wockhardt Limited (WOCKPHARMA)

Name: Wockhardt Limited (WOCKPHARMA) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-09-20

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products.

Números-chave

Capitalização de mercado: ₹339 billion
Receita (exercício encerrado em 2026-03-31): ₹33.2B
Lucro líquido: ₹2.1B
Margem bruta: 63.4%
Margem líquida: 6.4%

Ver gráficos interativos e demonstrações completas →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Receita total	₹33.2B	₹29.1B	₹27.9B	₹26.5B	—
Lucro bruto	₹21.0B	₹17.1B	₹15.7B	₹14.9B	—
Resultado Operacional (EBIT)	₹4.0B	₹1.8B	(₹530M)	(₹1.5B)	—
Resultado líquido	₹2.1B	(₹470M)	(₹4.6B)	(₹5.6B)	—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de WOCKPHARMA. /companies/us/WOCKPHARMA

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.